vs
Side-by-side financial comparison of IHS Holding Ltd (IHS) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $254.0M, roughly 1.9× IHS Holding Ltd). On growth, IHS Holding Ltd posted the faster year-over-year revenue change (0.1% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -22.0%).
IHS Towers is one of the largest independent owners, operators and developers of shared communications infrastructure in the world, with operations across Africa and Latin America. It is the fifth-largest independent multinational tower company in the world.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
IHS vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $254.0M | $493.8M |
| Net Profit | — | $33.7M |
| Gross Margin | 83.6% | — |
| Operating Margin | — | 9.9% |
| Net Margin | — | 6.8% |
| Revenue YoY | 0.1% | -1.7% |
| Net Profit YoY | — | 10.5% |
| EPS (diluted) | — | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $254.0M | $493.8M | ||
| Q3 25 | $455.1M | $492.9M | ||
| Q2 25 | $433.3M | $468.8M | ||
| Q1 25 | $439.6M | $458.4M | ||
| Q4 24 | $253.8M | $502.4M | ||
| Q3 24 | $420.3M | $511.2M | ||
| Q2 24 | $435.4M | $504.3M | ||
| Q1 24 | $417.7M | $495.1M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | $147.4M | $71.7M | ||
| Q2 25 | $32.3M | $39.3M | ||
| Q1 25 | $30.7M | $20.7M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $-205.7M | $19.4M | ||
| Q2 24 | $-124.3M | $-153.0M | ||
| Q1 24 | $-1.6B | $4.0M |
| Q4 25 | 83.6% | — | ||
| Q3 25 | 47.5% | — | ||
| Q2 25 | 51.3% | — | ||
| Q1 25 | 51.4% | — | ||
| Q4 24 | 72.1% | — | ||
| Q3 24 | 52.0% | — | ||
| Q2 24 | 52.5% | — | ||
| Q1 24 | 39.1% | — |
| Q4 25 | — | 9.9% | ||
| Q3 25 | 35.1% | 13.8% | ||
| Q2 25 | 33.8% | 12.8% | ||
| Q1 25 | 37.1% | 7.0% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | 29.9% | 6.6% | ||
| Q2 24 | 34.0% | -31.3% | ||
| Q1 24 | -1.7% | 3.2% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | 32.4% | 14.5% | ||
| Q2 25 | 7.5% | 8.4% | ||
| Q1 25 | 7.0% | 4.5% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | -48.9% | 3.8% | ||
| Q2 24 | -28.5% | -30.3% | ||
| Q1 24 | -372.8% | 0.8% |
| Q4 25 | — | $0.40 | ||
| Q3 25 | $0.44 | $0.84 | ||
| Q2 25 | $0.10 | $0.46 | ||
| Q1 25 | $0.10 | $0.24 | ||
| Q4 24 | — | $0.37 | ||
| Q3 24 | $-0.61 | $0.23 | ||
| Q2 24 | $-0.36 | $-1.84 | ||
| Q1 24 | $-4.67 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $825.7M | $375.2M |
| Total DebtLower is stronger | $3.1B | $570.5M |
| Stockholders' EquityBook value | $-89.8M | $865.9M |
| Total Assets | $4.5B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $825.7M | $375.2M | ||
| Q3 25 | $647.6M | $340.1M | ||
| Q2 25 | $531.8M | $224.7M | ||
| Q1 25 | $629.0M | $99.0M | ||
| Q4 24 | $578.0M | $229.9M | ||
| Q3 24 | $397.5M | $103.8M | ||
| Q2 24 | $445.7M | $19.4M | ||
| Q1 24 | $333.2M | $8.0M |
| Q4 25 | $3.1B | $570.5M | ||
| Q3 25 | $3.3B | $577.2M | ||
| Q2 25 | $3.2B | $583.9M | ||
| Q1 25 | $3.4B | $590.5M | ||
| Q4 24 | $3.3B | $597.1M | ||
| Q3 24 | $3.5B | — | ||
| Q2 24 | $3.6B | — | ||
| Q1 24 | $3.5B | — |
| Q4 25 | $-89.8M | $865.9M | ||
| Q3 25 | $38.1M | $890.7M | ||
| Q2 25 | $-98.4M | $833.8M | ||
| Q1 25 | $-184.4M | $789.2M | ||
| Q4 24 | $-314.4M | $764.9M | ||
| Q3 24 | $-284.7M | $732.5M | ||
| Q2 24 | $-308.3M | $706.5M | ||
| Q1 24 | $-163.2M | $856.2M |
| Q4 25 | $4.5B | $2.2B | ||
| Q3 25 | $4.7B | $2.2B | ||
| Q2 25 | $4.5B | $2.1B | ||
| Q1 25 | $4.4B | $2.0B | ||
| Q4 24 | $4.2B | $2.2B | ||
| Q3 24 | $4.6B | $2.1B | ||
| Q2 24 | $4.5B | $2.0B | ||
| Q1 24 | $4.6B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | 85.85× | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $246.9M | $114.1M |
| Free Cash FlowOCF − Capex | $178.6M | — |
| FCF MarginFCF / Revenue | 70.3% | — |
| Capex IntensityCapex / Revenue | 26.9% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $718.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $246.9M | $114.1M | ||
| Q3 25 | $251.3M | $137.3M | ||
| Q2 25 | $237.7M | $137.2M | ||
| Q1 25 | $200.3M | $-117.5M | ||
| Q4 24 | $344.4M | $133.0M | ||
| Q3 24 | $174.5M | $91.8M | ||
| Q2 24 | $134.7M | $107.0M | ||
| Q1 24 | $75.8M | $-125.2M |
| Q4 25 | $178.6M | — | ||
| Q3 25 | $189.2M | — | ||
| Q2 25 | $197.7M | — | ||
| Q1 25 | $153.2M | — | ||
| Q4 24 | $282.9M | — | ||
| Q3 24 | $122.3M | — | ||
| Q2 24 | $74.2M | — | ||
| Q1 24 | $14.8M | — |
| Q4 25 | 70.3% | — | ||
| Q3 25 | 41.6% | — | ||
| Q2 25 | 45.6% | — | ||
| Q1 25 | 34.8% | — | ||
| Q4 24 | 111.5% | — | ||
| Q3 24 | 29.1% | — | ||
| Q2 24 | 17.0% | — | ||
| Q1 24 | 3.5% | — |
| Q4 25 | 26.9% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 9.2% | — | ||
| Q1 25 | 10.7% | — | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 12.4% | — | ||
| Q2 24 | 13.9% | — | ||
| Q1 24 | 14.6% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | 1.70× | 1.91× | ||
| Q2 25 | 7.36× | 3.49× | ||
| Q1 25 | 6.52× | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IHS
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
